Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Important Facts About Masimo Stock

Shares of Health Care sector company Masimo moved 10.5% today, and are now trading at a price of $187.31. The Large-Cap stock's daily volume was 936,268 compared to its average volume of 469,294. The S&P 500 index returned a -0.0% performance.

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company is based in Irvine and has 3,800 full time employees. Its market capitalization is $10,028,689,408.

Over the last year, MASI's share price has increased by 31.7%, which represents a difference of 14.3% when compared to the S&P 500. The stock's 52 week high is $190.07 per share whereas its 52 week low is $101.61. Masimo's average free cash flow over the last 6 years has been $135.97 Million, but they have been decreasing at an average rate of -13.2%. This may prove a challenge to the long term sustainability of the stock's upwards trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 94,100 44,000 50,100 -79.05
2022 264,600 25,500 239,100 72.51
2021 211,100 72,500 138,600 -9.57
2019 221,642 68,375 153,267 -31.09
2018 239,527 17,126 222,401 1696.74
2017 56,062 43,684 12,378
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS